TITLE:
Analysis of Use and Outcomes of Peripherally Inserted Central Catheter (PICC-Line) in Hemato-Oncological Patients
AUTHORS:
Sulav Sapkota, Radheshyam Naik
KEYWORDS:
Peripherally Inserted Central Catheter (PICC), Vascular Access Device (VAD), Catheter-Related Bloodstream Infection (CR-BSI), Eastern Cooperative Oncology Group Performance Status (ECOG PS), Central Venous Catheter (CVC)
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.9 No.1,
January
25,
2018
ABSTRACT: Aims: To audit the use and outcomes of using PICC lines in
hemato-oncological patients. Objectives: To study the demographics of patients: studying the use of PICC line in hemato-oncological patients; studying the rate of complications in PICC line; studying the cause of early removal of PICC line. Methods: All PICCs
inserted in adult hemato-oncological patients in Hematology and Medical
Oncology Department of Health Care Global (HCG) Hospital were studied
prospectively, as per the proforma, till PICCs were removed or patient expired
and the pattern of complications were noted. Results: Eighty-four PICCs
were inserted over a period of initial nine months and followed for a total of
1 year with three months post insertion duration for a total of 10,868
catheter-days (mean of 129 days i.e. 4.3 months, range: 1 to 288 days). The most common indication for PICC was chemotherapy
(100%). Among them 19 (22%) PICCs had complications and 12 were removed at the rate of
1.1/1000 PICC-days. Complications with haematologic malignancies were more as
compared to those with solid tissue malignancies. Conclusions: Despite
significant complication rates, PICCs are a relatively safe and cost effective
mode of establishing central venous access.